When Tomahawk shut down in 2016, it was powered by a team of six. A decade later, developer J Herskowitz has vibe-coded it ...
Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results